Literature DB >> 11801632

Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice.

Shu-Cheng Chen1, Galya Vassileva, David Kinsley, Sandra Holzmann, Denise Manfra, Maria T Wiekowski, Nikolaus Romani, Sergio A Lira.   

Abstract

The CC chemokine CCL21 is a potent chemoattractant for lymphocytes and dendritic cells in vitro. In the murine genome there are multiple copies of CCL21 encoding two CCL21 proteins that differ from each other by one amino acid at position 65 (either a serine or leucine residue). In this report, we examine the expression pattern and biological activities of both forms of CCL21. We found that although both serine and leucine forms are expressed in most tissues examined, the former was the predominant form in lymphoid organs while the latter was predominantly expressed in nonlymphoid organs. When expressed in transgenic pancreas, both forms of CCL21 were capable of inducing the formation of lymph node-like structures composed primarily of T and B cells and a few dendritic cells. Induction of lymph node-like structures by these CCL21 proteins, however, could not be reproduced in every tissue. For instance, no lymphocyte recruitment or accumulation was observed when CCL21 was overexpressed in the skin. We conclude that both forms of CCL21 protein are biologically equivalent in promoting lymphocyte recruitment to the pancreas, and that their ability to induce the formation of lymph node-like structures is dependent on the tissues in which they are expressed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801632     DOI: 10.4049/jimmunol.168.3.1001

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  IL-17 initiates tertiary lymphoid organ formation.

Authors:  Xueguang Zhang; Binfeng Lu
Journal:  Cell Mol Immunol       Date:  2011-12-19       Impact factor: 11.530

2.  Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis.

Authors:  Eóin N McNamee; Joanne C Masterson; Paul Jedlicka; Colm B Collins; Ifor R Williams; Jesús Rivera-Nieves
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

3.  CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice.

Authors:  Zhongyan Shan; Baohui Xu; Anna Mikulowska-Mennis; Sara A Michie
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 4.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

Review 5.  Visualizing dendritic cell migration within the skin.

Authors:  Ben Roediger; Lai Guan Ng; Adrian L Smith; Barbara Fazekas de St Groth; Wolfgang Weninger
Journal:  Histochem Cell Biol       Date:  2008-11-06       Impact factor: 4.304

Review 6.  Dendritic cell interactions with lymphatic endothelium.

Authors:  Erica Russo; Maximilian Nitschké; Cornelia Halin
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

7.  Tertiary lymphoid organs in lymphatic malformations.

Authors:  Andrew L Kirsh; Sharon L Cushing; Eunice Y Chen; Stephen M Schwartz; Jonathan A Perkins
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

Review 8.  The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.

Authors:  Boris Calderon; Javier A Carrero; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2013-11-16       Impact factor: 7.486

Review 9.  The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.

Authors:  Andrew Filer; Karim Raza; Mike Salmon; Christopher D Buckley
Journal:  Front Biosci       Date:  2008-01-01

Review 10.  The Role of Lymphoid Neogenesis in Allografts.

Authors:  H-M Hsiao; W Li; A E Gelman; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.